158 / 464
158
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
TUESDAY 9 MAY 2017
SYMPOSIUMWITH PROFFERED PAPERS
Selection of patients and radiotherapy technique for APBI in the light of
new phase III trial data
09:15 - 10:30 | SCHUBERT
Chair: J. Guinot (Spain)
Co-chair: A. Resch (Austria)
09:15 > Target coverage and dose to organs at risk using different techniques of
APBI (EBI, IORT, BT)
L. Marrazzo (Italy)
SP-0565
09:33 > External beam partial breast irradiation: changing patient selection
based on current evidence
I. Meattini (Italy)
SP-0566
09:51 > Partial breast irradiation with brachytherapy: changing patient selection
based on current evidence
C. Polgár (Hungary)
SP-0567
10:09 > Accelerated PBI VS standard radiotherapy (IRMA trial): interim
cosmetic and toxicity results
B. Meduri (Italy), A. Baldissera, M. Galeandro, E. Donini, G. Tolento,
P. Giacobazzi, T. Calmieri, P. Vasilyeva, A.G. Morganti, S. Parisi, S. Kaleci,
F. Lohr, R. D’amico, P.M. Poortmans, F. Bertoni, G.P. Frezza
OC-0568
10:19 > Comparison of clinical outcome of APBI by interstitial brachytherapy
as per ESTRO and ASTRO guidelines
T. Telkhade (India), T. Wadasadawala, R. Upereti, R. Sarin, R. Jalali,
R. Badwe, V. Parmar, S. Gupta, A. Budrukkar
OC-0569
SYMPOSIUMWITH PROFFERED PAPERS
Novel approaches in poor tumour control sites
09:15 - 10:30 | LEHAR 4
Despite the overall progress in cancer detection and treatment, some cancers
remain difficult to detect early and poorly responsive to treatment, resulting in a
dismal outcome for the patients. Speakers in this symposium will discuss novel
approaches for the diagnosis and treatment of pancreatic and brain tumours, which
take advantage of innovative molecularly-based techniques. Data illustrating the
use of circulating tumour DNA for diagnostic and prognostic purposes will also be
presented using as example HPV ctDNA detection in patients treated for anal canal
squamous cell carcinoma.
Chair: S. Demaria (USA)
Co-chair: C. Doeller (Austria)